Les Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
NCT Number: NCT04385121
The hospitalization of a patient in intensive care is a traumatic experience for his family members.
With the current COVID-19 epidemic, in view of the high risk of contamination, drastic measures to limit the transmission are necessary, with the creation of spaces dedicated to the care of Covid+ patients, and family are not allowed to visit.
At the Strasbourg University Hospital, visits were prohibited from the start of the epidemic. Information concerning the patient's state of health is therefore delivered to families by telephone, on call by the healthcare team only, every day before 6 p.m. or in the event of a serious event at any time.
The primary purpose of this project is to assess the psychological impact of the hospitalization of a loved one in intensive care for Covid-19 infection at 3 months post-hospitalization, in a context of pandemic with ban on visits.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Strasbourg, 67091, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Family member's will answer the questionnaires by phone
Time frame: 3 months
An overall score of 19 or more indicates a major depressive episode (HAD) and a total score of 22 as in favor of significant symptoms of acute stress (IES-R)
University Hospital, Strasbourg, France
Other
Acronym: Familles-COVID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05092529
Anxiety, Anxiety Disorders
Truro, Cornwall, United Kingdom
View Trial DetailsNCT04385238
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT04397848
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT06119854
Anxiety, Anxiety Disorders
New York, United States
View Trial Details